Visium Asset Management LP, the $8 billion New York-based healthcare hedge fund spin-off from Balyasny Asset Management operated by Dr. Jacob Gottlieb, is being investigated, according to a letter to investors obtained by ValueWalk. Long / short strategy play, best known for its health care expertise, is under investigation for trading and valuation issues, Visium letter to investors says In an note sent to investors this morning and first reported by Gregory Zuckerman in The Wall Street Journal, Visium said the U.S. Department of Justice and the Securities and Exchange Commission are reviewing trading and valuation issues. Investigators “have requested information…
On This Page
- Long / short strategy play, best known for its health care expertise, is under investigation for trading and valuation issues, Visium letter to investors says
- Visium says it is fully cooperating, but with DoJ is involved in a financial services related investigation, a heightened degree of interest is at hand
This content is exclusively for paying members of Hedge Fund Alpha
Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!
